{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:34:54Z","timestamp":1794854094076,"version":"4.9.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T00:00:00Z","timestamp":1529884800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Jilin province science and technology development plan","award":["20160101135JC"],"award-info":[{"award-number":["20160101135JC"]}]},{"name":"Jilin province science and technology development plan","award":["20150311066YY"],"award-info":[{"award-number":["20150311066YY"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12931-018-0832-x","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T07:42:23Z","timestamp":1529912543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Interleukin-32: its role in asthma and potential as a therapeutic agent"],"prefix":"10.1186","volume":"19","author":[{"given":"Tong","family":"Xin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7328-1235","authenticated-orcid":false,"given":"Peng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,25]]},"reference":[{"key":"832_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.pharmthera.2017.02.025","volume":"174","author":"JT Hong","year":"2017","unstructured":"Hong JT, Son DJ, Lee CK, Yoon DY, Lee DH, Park MH. Interleukin 32, inflammation and cancer. Pharmacol Ther. 2017;174:127\u201337.","journal-title":"Pharmacol Ther"},{"key":"832_CR2","doi-asserted-by":"publisher","first-page":"e1985","DOI":"10.1371\/journal.pone.0001985","volume":"3","author":"W Li","year":"2008","unstructured":"Li W, Liu Y, Mukhtar MM, Gong R, Pan Y, Rasool ST, et al. Activation of interleukin-32 pro-inflammatory pathway in response to influenza a virus infection. PLoS One. 2008;3:e1985.","journal-title":"PLoS One"},{"key":"832_CR3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4049\/jimmunol.148.2.597","volume":"148","author":"CA Dahl","year":"1992","unstructured":"Dahl CA, Schall RP, He HL, Cairns JS. Identification of a novel gene expressed in activated natural killer cells and T cells. J Immunol. 1992;148:597\u2013603.","journal-title":"J Immunol"},{"key":"832_CR4","first-page":"131","volume":"22","author":"SH Kim","year":"2005","unstructured":"Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity. 2005;22:131\u201342.","journal-title":"Immunity"},{"key":"832_CR5","doi-asserted-by":"crossref","unstructured":"Panelli MC, Wang E, Phan G, Puhlmann M, Miller L, Ohnmacht GA, et al. Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration. Genome Biol. 2002;3:RESEARCH0035.","DOI":"10.1186\/gb-2002-3-7-research0035"},{"key":"832_CR6","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/j.1398-9995.2012.02820.x","volume":"67","author":"MB Soyka","year":"2012","unstructured":"Soyka MB, Treis A, Eiwegger T, Menz G, Zhang S, Holzmann D, et al. Regulation and expression of IL-32 in chronic rhinosinusitis. Allergy. 2012;67:790\u20138.","journal-title":"Allergy"},{"key":"832_CR7","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1073\/pnas.0712381105","volume":"105","author":"MG Netea","year":"2008","unstructured":"Netea MG, Lewis EC, Azam T, Joosten LA, Jaekal J, Bae SY, et al. Interleukin-32 induces the differentiation of monocytes into macrophage-like cells. Proc Natl Acad Sci U S A. 2008;105:3515\u201320.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"832_CR8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/art.27197","volume":"62","author":"YG Kim","year":"2010","unstructured":"Kim YG, Lee CK, Oh JS, Kim SH, Kim KA, Yoo B. Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes. Arthritis Rheum. 2010;62:515\u201323.","journal-title":"Arthritis Rheum"},{"key":"832_CR9","doi-asserted-by":"publisher","first-page":"e4173","DOI":"10.1371\/journal.pone.0004173","volume":"4","author":"G Mabilleau","year":"2009","unstructured":"Mabilleau G, Sabokbar A. Interleukin-32 promotes osteoclast differentiation but not osteoclast activation. PLoS One. 2009;4:e4173.","journal-title":"PLoS One"},{"key":"832_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/intimm\/dxh339","volume":"18","author":"C Goda","year":"2006","unstructured":"Goda C, Kanaji T, Kanaji S, Tanaka G, Arima K, Ohno S, et al. Involvement of IL-32 in activation-induced cell death in T cells. Int Immunol. 2006;18:233\u201340.","journal-title":"Int Immunol"},{"key":"832_CR11","first-page":"858\u201365 e10","volume":"125","author":"N Meyer","year":"2010","unstructured":"Meyer N, Zimmermann M, Burgler S, Bassin C, Woehrl S, Moritz K, et al. IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J Allergy Clin Immunol. 2010;125:858\u201365 e10.","journal-title":"J Allergy Clin Immunol"},{"key":"832_CR12","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1136\/ard.2010.139196","volume":"70","author":"B Heinhuis","year":"2011","unstructured":"Heinhuis B, Koenders MI, van Riel PL, van de Loo FA, Dinarello CA, Netea MG, et al. Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade. Ann Rheum Dis. 2011;70:660\u20137.","journal-title":"Ann Rheum Dis"},{"key":"832_CR13","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.1073\/pnas.1016005108","volume":"108","author":"B Heinhuis","year":"2011","unstructured":"Heinhuis B, Koenders MI, van de Loo FA, Netea MG, van den Berg WB, Joosten LA. Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2011;108:4962\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"832_CR14","doi-asserted-by":"publisher","first-page":"e532","DOI":"10.1111\/j.1365-2567.2008.03025.x","volume":"128","author":"JW Kang","year":"2009","unstructured":"Kang JW, Choi SC, Cho MC, Kim HJ, Kim JH, Lim JS, et al. A proinflammatory cytokine interleukin-32beta promotes the production of an anti-inflammatory cytokine interleukin-10. Immunology. 2009;128:e532\u201340.","journal-title":"Immunology"},{"issue":"Suppl 3","key":"832_CR15","doi-asserted-by":"crossref","first-page":"iii61","DOI":"10.1136\/ard.2006.058511","volume":"65","author":"CA Dinarello","year":"2006","unstructured":"Dinarello CA, Kim SH. IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis. 2006;65(Suppl 3):iii61\u20134.","journal-title":"Ann Rheum Dis"},{"key":"832_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cyto.2012.07.010","volume":"60","author":"B Heinhuis","year":"2012","unstructured":"Heinhuis B, Netea MG, van den Berg WB, Dinarello CA, Joosten LA. Interleukin-32: a predominantly intracellular proinflammatory mediator that controls cell activation and cell death. Cytokine. 2012;60:321\u20137.","journal-title":"Cytokine"},{"key":"832_CR17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.4049\/jimmunol.1202802","volume":"192","author":"CA Nold-Petry","year":"2014","unstructured":"Nold-Petry CA, Rudloff I, Baumer Y, Ruvo M, Marasco D, Botti P, et al. IL-32 promotes angiogenesis. J Immunol. 2014;192:589\u2013602.","journal-title":"J Immunol"},{"key":"832_CR18","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1128\/IAI.00637-12","volume":"80","author":"K Sakitani","year":"2012","unstructured":"Sakitani K, Hirata Y, Hayakawa Y, Serizawa T, Nakata W, Takahashi R, et al. Role of interleukin-32 in helicobacter pylori-induced gastric inflammation. Infect Immun. 2012;80:3795\u2013803.","journal-title":"Infect Immun"},{"key":"832_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cyto.2010.09.002","volume":"53","author":"H Hasegawa","year":"2011","unstructured":"Hasegawa H, Thomas HJ, Schooley K, Born TL. Native IL-32 is released from intestinal epithelial cells via a non-classical secretory pathway as a membrane-associated protein. Cytokine. 2011;53:74\u201383.","journal-title":"Cytokine"},{"key":"832_CR20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.cyto.2009.03.007","volume":"46","author":"H Kobayashi","year":"2009","unstructured":"Kobayashi H, Lin PC. Molecular characterization of IL-32 in human endothelial cells. Cytokine. 2009;46:351\u20138.","journal-title":"Cytokine"},{"key":"832_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4110\/in.2014.14.3.123","volume":"14","author":"S Kim","year":"2014","unstructured":"Kim S. Interleukin-32 in inflammatory autoimmune diseases. Immune Netw. 2014;14:123\u20137.","journal-title":"Immune Netw"},{"key":"832_CR22","doi-asserted-by":"publisher","first-page":"16309","DOI":"10.1073\/pnas.0508237102","volume":"102","author":"MG Netea","year":"2005","unstructured":"Netea MG, Azam T, Ferwerda G, Girardin SE, Walsh M, Park JS, et al. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci U S A. 2005;102:16309\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"832_CR23","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.biochi.2014.01.013","volume":"101","author":"JW Kang","year":"2014","unstructured":"Kang JW, Park YS, Lee DH, Kim MS, Bak Y, Ham SY, et al. Interaction network mapping among IL-32 isoforms. Biochimie. 2014;101:248\u201351.","journal-title":"Biochimie"},{"key":"832_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cellimm.2010.04.010","volume":"264","author":"JI Chae","year":"2010","unstructured":"Chae JI, Shim JH, Lee KS, Cho YS, Lee KS, Yoon DY, et al. Downregulation of immune response by the human cytokines interleukin-32alpha and beta in cell-mediated rejection. Cell Immunol. 2010;264:47\u201353.","journal-title":"Cell Immunol"},{"key":"832_CR25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/oby.21001","volume":"23","author":"DH Lee","year":"2015","unstructured":"Lee DH, Hong JE, Yun HM, Hwang CJ, Park JH, Han SB, et al. Interleukin-32beta ameliorates metabolic disorder and liver damage in mice fed high-fat diet. Obesity (Silver Spring). 2015;23:615\u201322.","journal-title":"Obesity (Silver Spring)"},{"key":"832_CR26","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.4014\/jmb.1404.04012","volume":"24","author":"SJ Kim","year":"2014","unstructured":"Kim SJ, Lee S, Kwak A, Kim E, Jo S, Bae S, et al. Interleukin-32gamma transgenic mice resist LPS-mediated septic shock. J Microbiol Biotechnol. 2014;24:1133\u201342.","journal-title":"J Microbiol Biotechnol"},{"key":"832_CR27","doi-asserted-by":"crossref","unstructured":"Kang JW, Park YS, Lee DH, Kim MS, Bak Y, Park SH, et al. Interleukin-32delta interacts with IL-32beta and inhibits IL-32beta-mediated IL-10 production. FEBS Lett. 2013;587:3776\u201381.","DOI":"10.1016\/j.febslet.2013.10.019"},{"key":"832_CR28","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.4049\/jimmunol.0902667","volume":"185","author":"W Li","year":"2010","unstructured":"Li W, Sun W, Liu L, Yang F, Li Y, Chen Y, et al. IL-32: a host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza a virus infection. J Immunol. 2010;185:5056\u201365.","journal-title":"J Immunol"},{"key":"832_CR29","doi-asserted-by":"publisher","first-page":"557","DOI":"10.4049\/jimmunol.181.1.557","volume":"181","author":"MF Nold","year":"2008","unstructured":"Nold MF, Nold-Petry CA, Pott GB, Zepp JA, Saavedra MT, Kim SH, et al. Endogenous IL-32 controls cytokine and HIV-1 production. J Immunol. 2008;181:557\u201365.","journal-title":"J Immunol"},{"key":"832_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.imlet.2008.01.007","volume":"117","author":"ST Rasool","year":"2008","unstructured":"Rasool ST, Tang H, Wu J, Li W, Mukhtar MM, Zhang J, et al. Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication. Immunol Lett. 2008;117:161\u20137.","journal-title":"Immunol Lett"},{"key":"832_CR31","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.4049\/jimmunol.1000081","volume":"186","author":"JA Zepp","year":"2011","unstructured":"Zepp JA, Nold-Petry CA, Dinarello CA, Nold MF. Protection from RNA and DNA viruses by IL-32. J Immunol. 2011;186:4110\u20138.","journal-title":"J Immunol"},{"key":"832_CR32","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1073\/pnas.0813334106","volume":"106","author":"CA Nold-Petry","year":"2009","unstructured":"Nold-Petry CA, Nold MF, Zepp JA, Kim SH, Voelkel NF, Dinarello CA. IL-32-dependent effects of IL-1beta on endothelial cell functions. Proc Natl Acad Sci U S A. 2009;106:3883\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"832_CR33","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1164\/rccm.200804-646OC","volume":"178","author":"F Calabrese","year":"2008","unstructured":"Calabrese F, Baraldo S, Bazzan E, Lunardi F, Rea F, Maestrelli P, et al. IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;178:894\u2013901.","journal-title":"Am J Respir Crit Care Med"},{"key":"832_CR34","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S1995-7645(14)60177-2","volume":"7","author":"TG Jia","year":"2014","unstructured":"Jia TG, Zhao JQ, Liu JH. Serum inflammatory factor and cytokines in AECOPD. Asian Pac J Trop Med. 2014;7:1005\u20138.","journal-title":"Asian Pac J Trop Med"},{"key":"832_CR35","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1073\/pnas.0511233103","volume":"103","author":"LA Joosten","year":"2006","unstructured":"Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers-Walgreen B, Radstake TR, et al. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2006;103:3298\u2013303.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"832_CR36","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1016\/j.rmed.2014.10.010","volume":"108","author":"A Brandelius","year":"2014","unstructured":"Brandelius A, Andersson M, Uller L. Topical dsRNA challenges may induce overexpression of airway antiviral cytokines in symptomatic allergic disease. A pilot in vivo study in nasal airways. Respir Med. 2014;108:1816\u20139.","journal-title":"Respir Med"},{"key":"832_CR37","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3109\/01902148.2015.1033569","volume":"41","author":"K Ota","year":"2015","unstructured":"Ota K, Kawaguchi M, Fujita J, Kokubu F, Huang SK, Morishima Y, et al. Synthetic double-stranded RNA induces interleukin-32 in bronchial epithelial cells. Exp Lung Res. 2015;41:335\u201343.","journal-title":"Exp Lung Res"},{"key":"832_CR38","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1042\/CS20160939","volume":"131","author":"C Herbert","year":"2017","unstructured":"Herbert C, Do K, Chiu V, Garthwaite L, Chen Y, Young PM, et al. Allergic environment enhances airway epithelial pro-inflammatory responses to rhinovirus infection. Clin Sci (Lond). 2017;131:499\u2013509.","journal-title":"Clin Sci (Lond)"},{"key":"832_CR39","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nm.2650","volume":"18","author":"M Schenk","year":"2012","unstructured":"Schenk M, Krutzik SR, Sieling PA, Lee DJ, Teles RM, Ochoa MT, et al. NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosy. Nat Med. 2012;18:555\u201363.","journal-title":"Nat Med"},{"key":"832_CR40","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/path.2899","volume":"224","author":"HJ Jeong","year":"2011","unstructured":"Jeong HJ, Shin SY, Oh HA, Kim MH, Cho JS, Kim HM. IL-32 up-regulation is associated with inflammatory cytokine production in allergic rhinitis. J Pathol. 2011;224:553\u201363.","journal-title":"J Pathol"},{"key":"832_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1164\/rccm.200904-0545OC","volume":"181","author":"CM Greene","year":"2010","unstructured":"Greene CM, Low TB, O'Neill SJ, McElvaney NG. Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease. Am J Respir Crit Care Med. 2010;181:31\u20135.","journal-title":"Am J Respir Crit Care Med"},{"key":"832_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1465-9921-13-19","volume":"13","author":"M Kudo","year":"2012","unstructured":"Kudo M, Ogawa E, Kinose D, Haruna A, Takahashi T, Tanabe N, et al. Oxidative stress induced interleukin-32 mRNA expression in human bronchial epithelial cells. Respir Res. 2012;13:19.","journal-title":"Respir Res"},{"key":"832_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cyto.2011.12.024","volume":"58","author":"S Bae","year":"2012","unstructured":"Bae S, Kang D, Hong J, Chung B, Choi J, Jhun H, et al. Characterizing antiviral mechanism of interleukin-32 and a circulating soluble isoform in viral infection. Cytokine. 2012;58:79\u201386.","journal-title":"Cytokine"},{"key":"832_CR44","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1016\/j.cellsig.2014.09.015","volume":"26","author":"Y Bak","year":"2014","unstructured":"Bak Y, Kang JW, Kim MS, Park YS, Kwon T, Kim S, et al. IL-32theta downregulates CCL5 expression through its interaction with PKCdelta and STAT3. Cell Signal. 2014;26:3007\u201315.","journal-title":"Cell Signal"},{"key":"832_CR45","doi-asserted-by":"crossref","first-page":"40747","DOI":"10.18632\/oncotarget.5688","volume":"6","author":"MS Kim","year":"2015","unstructured":"Kim MS, Kang JW, Jeon JS, Kim JK, Kim JW, Hong J, et al. IL-32theta gene expression in acute myeloid leukemia suppresses TNF-alpha production. Oncotarget. 2015;6:40747\u201361.","journal-title":"Oncotarget"},{"key":"832_CR46","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1016\/j.febslet.2014.06.029","volume":"588","author":"MS Kim","year":"2014","unstructured":"Kim MS, Kang JW, Lee DH, Bak Y, Park YS, Song YS, et al. IL-32theta negatively regulates IL-1beta production through its interaction with PKCdelta and the inhibition of PU.1 phosphorylation. FEBS Lett. 2014;588:2822\u20139.","journal-title":"FEBS Lett"},{"key":"832_CR47","doi-asserted-by":"publisher","first-page":"21082","DOI":"10.1073\/pnas.1015418107","volume":"107","author":"J Choi","year":"2010","unstructured":"Choi J, Bae S, Hong J, Ryoo S, Jhun H, Hong K, et al. Paradoxical effects of constitutive human IL-32{gamma} in transgenic mice during experimental colitis. Proc Natl Acad Sci U S A. 2010;107:21082\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"832_CR48","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2567.2008.02917.x","volume":"126","author":"JD Choi","year":"2009","unstructured":"Choi JD, Bae SY, Hong JW, Azam T, Dinarello CA, Her E, et al. Identification of the most active interleukin-32 isoform. Immunology. 2009;126:535\u201342.","journal-title":"Immunology"},{"key":"832_CR49","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1189\/jlb.0813452","volume":"95","author":"CK Wong","year":"2014","unstructured":"Wong CK, Dong J, Lam CW. Molecular mechanisms regulating the synergism between IL-32gamma and NOD for the activation of eosinophils. J Leukoc Biol. 2014;95:631\u201342.","journal-title":"J Leukoc Biol"},{"key":"832_CR50","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1165\/rcmb.2013-0234OC","volume":"50","author":"BR Bang","year":"2014","unstructured":"Bang BR, Kwon HS, Kim SH, Yoon SY, Choi JD, Hong GH, et al. Interleukin-32gamma suppresses allergic airway inflammation in mouse models of asthma. Am J Respir Cell Mol Biol. 2014;50:1021\u201330.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"832_CR51","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1056\/NEJM200102013440507","volume":"344","author":"WW Busse","year":"2001","unstructured":"Busse WW, Lemanske RF Jr. Asthma. N Engl J Med. 2001;344:350\u201362.","journal-title":"N Engl J Med"},{"key":"832_CR52","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1183\/09031936.00138707","volume":"31","author":"ED Bateman","year":"2008","unstructured":"Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31:143\u201378.","journal-title":"Eur Respir J"},{"key":"832_CR53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000090230","volume":"91","author":"AB Kay","year":"2006","unstructured":"Kay AB. The role of T lymphocytes in asthma. Chem Immunol Allergy. 2006;91:59\u201375.","journal-title":"Chem Immunol Allergy"},{"key":"832_CR54","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nri2254","volume":"8","author":"PJ Barnes","year":"2008","unstructured":"Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2008;8:183\u201392.","journal-title":"Nat Rev Immunol"},{"key":"832_CR55","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1440-1843.2006.00784.x","volume":"11","author":"JL Simpson","year":"2006","unstructured":"Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006;11:54\u201361.","journal-title":"Respirology"},{"key":"832_CR56","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJMoa0808991","volume":"360","author":"P Haldar","year":"2009","unstructured":"Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med. 2009;360:973\u201384.","journal-title":"N Engl J Med"},{"key":"832_CR57","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","volume":"180","author":"PG Woodruff","year":"2009","unstructured":"Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med. 2009;180:388\u201395.","journal-title":"Am J Respir Crit Care Med"},{"key":"832_CR58","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.2174\/138161212800166077","volume":"18","author":"E Mortaz","year":"2012","unstructured":"Mortaz E, Masjedi MR, Allameh A, Adcock IM. Inflammasome signaling in pathogenesis of lung diseases. Curr Pharm Des. 2012;18:2320\u20138.","journal-title":"Curr Pharm Des"},{"key":"832_CR59","doi-asserted-by":"publisher","first-page":"L627","DOI":"10.1152\/ajplung.00225.2012","volume":"303","author":"G dos Santos","year":"2012","unstructured":"dos Santos G, Kutuzov MA, Ridge KM. The inflammasome in lung diseases. Am J Physiol Lung Cell Mol Physiol. 2012;303:L627\u201333.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"832_CR60","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.rmed.2017.06.005","volume":"129","author":"JW Kwon","year":"2017","unstructured":"Kwon JW, Chang HS, Heo JS, Bae DJ, Lee JU, Jung CA, et al. Characteristics of asthmatics with detectable IL-32gamma in induced sputum. Respir Med. 2017;129:85\u201390.","journal-title":"Respir Med"},{"key":"832_CR61","doi-asserted-by":"publisher","first-page":"964\u201373 e7","DOI":"10.1016\/j.jaci.2011.12.1002","volume":"129","author":"N Meyer","year":"2012","unstructured":"Meyer N, Christoph J, Makrinioti H, Indermitte P, Rhyner C, Soyka M, et al. Inhibition of angiogenesis by IL-32: possible role in asthma. J Allergy Clin Immunol. 2012;129:964\u201373 e7.","journal-title":"J Allergy Clin Immunol"},{"key":"832_CR62","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3109\/15412555.2016.1145201","volume":"13","author":"E Gasiuniene","year":"2016","unstructured":"Gasiuniene E, Lavinskiene S, Sakalauskas R, Sitkauskiene B. Levels of IL-32 in serum, induced sputum supernatant, and bronchial lavage fluid of patients with chronic obstructive pulmonary disease. COPD. 2016;13:569\u201375.","journal-title":"COPD"},{"key":"832_CR63","first-page":"2460206","volume":"2016","author":"Y Wang","year":"2016","unstructured":"Wang Y, Zhou B, Zhao Y, Yu X, Liu Y, Zhang L. Association of Plasma IL-32 levels and gene polymorphisms with systemic lupus Erythematosus in Chinese Han population. Dis Markers. 2016;2016:2460206.","journal-title":"Dis Markers"},{"key":"832_CR64","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ijcard.2017.03.065","volume":"243","author":"W Xuan","year":"2017","unstructured":"Xuan W, Huang W, Wang R, Chen C, Chen Y, Wang Y, et al. Elevated circulating IL-32 presents a poor prognostic outcome in patients with heart failure after myocardial infarction. Int J Cardiol. 2017;243:367\u201373.","journal-title":"Int J Cardiol"},{"key":"832_CR65","doi-asserted-by":"crossref","unstructured":"Ha YJ, Park JS, Kang MI, Lee SK, Park YB, Lee SW. Increased serum interleukin-32 levels in patients with Behcet's disease. Int J Rheum Dis. 2017. [Epub ahead of print].","DOI":"10.1111\/1756-185X.13072"},{"key":"832_CR66","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/art.24299","volume":"60","author":"SH Mun","year":"2009","unstructured":"Mun SH, Kim JW, Nah SS, Ko NY, Lee JH, Kim JD, et al. Tumor necrosis factor alpha-induced interleukin-32 is positively regulated via the Syk\/protein kinase Cdelta\/JNK pathway in rheumatoid synovial fibroblasts. Arthritis Rheum. 2009;60:678\u201385.","journal-title":"Arthritis Rheum"},{"key":"832_CR67","doi-asserted-by":"crossref","first-page":"92841","DOI":"10.18632\/oncotarget.21611","volume":"8","author":"X Lin","year":"2017","unstructured":"Lin X, Yang L, Wang G, Zi F, Yan H, Guo X, et al. Interleukin-32alpha promotes the proliferation of multiple myeloma cells by inducing production of IL-6 in bone marrow stromal cells. Oncotarget. 2017;8:92841\u201354.","journal-title":"Oncotarget"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-018-0832-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-018-0832-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-018-0832-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T04:56:17Z","timestamp":1751691377000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-018-0832-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,25]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["832"],"URL":"https:\/\/doi.org\/10.1186\/s12931-018-0832-x","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,25]]},"assertion":[{"value":"7 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"124"}}